skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar solo
Refinado por: materia: Pharmacology. Drug Treatments eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Is birth weight related to later glucose and insulin metabolism?-a systematic review
Is birth weight related to later glucose and insulin metabolism?-a systematic review
Material Type:
Artículo 		Añadir a Mi Portal

Is birth weight related to later glucose and insulin metabolism?-a systematic review

Newsome, C. A. ; Shiell, A. W. ; Fall, C. H. D. ; Phillips, D. I. W. ; Shier, R. ; Law, C. M.

Diabetic medicine, 2003-05, Vol.20 (5), p.339-348 [Revista revisada por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponible

Citas Citado por
2
Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy
Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy
Material Type:
Artículo 		Añadir a Mi Portal

Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy

LEWIS PHILLIPS, Gail D ; FIELDS, Carter T ; DIERAS, Veronique ; CRIVELLARI, Diana ; LIANG FANG ; GUARDINO, Ellie ; OLSEN, Steven R ; CROCKER, Lisa M ; SLIWKOWSKI, Mark X ; GUANGMIN LI ; DOWBENKO, Donald ; SCHAEFER, Gabriele ; MILLER, Kathy ; ANDRE, Fabrice ; BURRIS, Howard A ; ALBAIN, Kathy S ; HARBECK, Nadia

Clinical cancer research, 2014-01, Vol.20 (2), p.456-468 [Revista revisada por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponible

Citas Citado por
3
Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
Material Type:
Artículo 		Añadir a Mi Portal

Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

JUNUTULA, Jagath R ; FLAGELLA, Kelly M ; MAI, Elaine ; LEWIS PHILLIPS, Gail D ; HIRARAGI, Hajime ; FUJI, Reina N ; TIBBITTS, Jay ; VANDLEN, Richard ; SPENCER, Susan D ; SCHELLER, Richard H ; POLAKIS, Paul ; SLIWKOWSKI, Mark X ; GRAHAM, Richard A ; PARSONS, Kathryn L ; HA, Edward ; RAAB, Helga ; BHAKTA, Sunil ; NGUYEN, Trung ; DUGGER, Debra L ; GUANGMIN LI

Clinical cancer research, 2010-10, Vol.16 (19), p.4769-4778 [Revista revisada por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponible

Citas Citado por
4
Navitoclax (ABT‐263) and bendamustine ± rituximab induce enhanced killing of non‐Hodgkin's lymphoma tumours in vivo
Navitoclax (ABT‐263) and bendamustine ± rituximab induce enhanced killing of non‐Hodgkin's lymphoma tumours in vivo
Material Type:
Artículo 		Añadir a Mi Portal

Navitoclax (ABT‐263) and bendamustine ± rituximab induce enhanced killing of non‐Hodgkin's lymphoma tumours in vivo

Ackler, S ; Mitten, MJ ; Chen, J ; Clarin, J ; Foster, K ; Jin, S ; Phillips, DC ; Schlessinger, S ; Wang, B ; Leverson, JD ; Boghaert, ER

British journal of pharmacology, 2012-10, Vol.167 (4), p.881-891 [Revista revisada por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponible

Citas Citado por
5
A combined spectroscopic and crystallographic approach to probing drug–human serum albumin interactions
A combined spectroscopic and crystallographic approach to probing drug–human serum albumin interactions
Material Type:
Artículo 		Añadir a Mi Portal

A combined spectroscopic and crystallographic approach to probing drug–human serum albumin interactions

Buttar, David ; Colclough, Nicola ; Gerhardt, Stefan ; MacFaul, Philip A. ; Phillips, Scott D. ; Plowright, Alleyn ; Whittamore, Paul ; Tam, Kin ; Maskos, Klaus ; Steinbacher, Stefan ; Steuber, Holger

Bioorganic & medicinal chemistry, 2010-11, Vol.18 (21), p.7486-7496 [Revista revisada por pares]

Amsterdam: Elsevier Ltd

Texto completo disponible

Citas Citado por
6
Developmental Programming: Deficits in Reproductive Hormone Dynamics and Ovulatory Outcomes in Prenatal, Testosterone-Treated Sheep
Developmental Programming: Deficits in Reproductive Hormone Dynamics and Ovulatory Outcomes in Prenatal, Testosterone-Treated Sheep
Material Type:
Artículo 		Añadir a Mi Portal

Developmental Programming: Deficits in Reproductive Hormone Dynamics and Ovulatory Outcomes in Prenatal, Testosterone-Treated Sheep

Veiga-Lopez, A ; Ye, W ; Phillips, D.J ; Herkimer, C ; Knight, P.G ; Padmanabhan, V

Biology of reproduction, 2008-04, Vol.78 (4), p.636-647 [Revista revisada por pares]

Madison, WI: Society for the Study of Reproduction, Inc

Texto completo disponible

Citas Citado por
7
Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugates
Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugates
Material Type:
Artículo 		Añadir a Mi Portal

Mechanistic pharmacokinetic/pharmacodynamic modeling of in vivo tumor uptake, catabolism, and tumor response of trastuzumab maytansinoid conjugates

Wada, Russ ; Erickson, Hans K. ; Lewis Phillips, Gail D. ; Provenzano, Carmela A. ; Leipold, Douglas D. ; Mai, Elaine ; Johnson, Holly ; Tibbitts, Jay

Cancer chemotherapy and pharmacology, 2014-11, Vol.74 (5), p.969-980 [Revista revisada por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponible

Citas Citado por
8
Understanding the genotoxicity of tamoxifen?
Understanding the genotoxicity of tamoxifen?
Material Type:
Artículo 		Añadir a Mi Portal

Understanding the genotoxicity of tamoxifen?

PHILLIPS, David H

Carcinogenesis (New York), 2001-06, Vol.22 (6), p.839-849 [Revista revisada por pares]

Oxford: Oxford University Press

Texto completo disponible

Citas Citado por
9
Development of Ruthenium Antitumor Drugs that Overcome Multidrug Resistance Mechanisms
Development of Ruthenium Antitumor Drugs that Overcome Multidrug Resistance Mechanisms
Material Type:
Artículo 		Añadir a Mi Portal

Development of Ruthenium Antitumor Drugs that Overcome Multidrug Resistance Mechanisms

Vock, Carsten A ; Ang, Wee Han ; Scolaro, Claudine ; Phillips, Andrew D ; Lagopoulos, Lucienne ; Juillerat-Jeanneret, Lucienne ; Sava, Gianni ; Scopelliti, Rosario ; Dyson, Paul J

Journal of medicinal chemistry, 2007-05, Vol.50 (9), p.2166-2175 [Revista revisada por pares]

Washington, DC: American Chemical Society

Texto completo disponible

Citas Citado por
10
Increase in US medication-error deaths between 1983 and 1993
Increase in US medication-error deaths between 1983 and 1993
Material Type:
Artículo 		Añadir a Mi Portal

Increase in US medication-error deaths between 1983 and 1993

Phillips, David P ; Christenfeld, Nicholas ; Glynn, Laura M

The Lancet (British edition), 1998-02, Vol.351 (9103), p.643-644 [Revista revisada por pares]

London: Elsevier Ltd

Texto completo disponible

Citas Citado por
Resultados 1 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Revistas arbitradas (682)

Refinar mis resultados

Tipo de Recurso 

  1. Artículos  (696)
  2. Actas de Congreso  (7)
  3. Más opciones open sub menu

Fecha de Publicación 

De Hasta
Refinar
  1. Antes de1988  (52)
  2. 1988Hasta1993  (111)
  3. 1994Hasta1999  (179)
  4. 2000Hasta2006  (202)
  5. Después de 2006  (160)
  6. Más opciones open sub menu

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora